Siduma Therapeutics, Inc. — Form D
Siduma Therapeutics, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-18. The offering totals $31.2M, of which $31.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-18
- Form: D
- Accession: 0001894519-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $31.2M
- Amount sold: $31.2M
- Investors: 11
- Date of first sale: 2021-11-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421617
Issuer
- Name: Siduma Therapeutics, Inc.
- CIK: 0001894519
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 286 LIVINGSTON STREET, NEW HAVEN, CT, 06511
- Phone: 2036875525
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Craig Crews | Director | New Haven, CT |
| Rebecca Frey | Director | Madison, CT |
| Timothy Shannon | Director | Stamford, CT |
| Craig Crews | Executive Officer | New Haven, CT |
More